Preliminary characterization of a new androgen-binding protein in human seminal plasma

Androgen-Binding Components of Human Semen

Androgen-binding components were detected in human semen, using the dextran-coated charcoal method. Pre- and postvasectomy semen samples did not show significant differences in ability to bind dihydrotestosterone. Electrophoresis conducted in polyacrylamide gels in which tritiated dihydrotestosterone had been incorporated disclosed the presence of androgen-binding protein with properties characteristic of the ABP of Sertoli cell origin in ram semen but ABP was not detectable in human semen, even after concentrating it two or four fold. The binding of dihydrotestosterone was slightly greater in the later portion of split-ejaculate samples, but binding was found in the earlier fraction and in prostatic fluid, suggesting that androgen-binding components enter human semen with secretions of the prostate and seminal vesicle glands. It was concluded that the extent of androgen-binding by human seminal fluid is not a measure of Sertoli-cell function.

Steroid analysis for medical diagnosis

Steroid assays are important for medical diagnosis of diseases related to steroid disturbances and abuse. This article reviews the recent progress in analytical methods for steroids in the clinical laboratory. The requirements for these methods are rapid, highly sensitive, specific, direct assay of conjugated steroids, the simultaneous analysis, identification of unknown steroids, and ultra-miniaturization of the separation system.

Androgen-binding proteins from human hyperplastic prostate as evaluated by electrophoresis

Until 1972 it was shown that the androgen action in the prostatic tissue was through receptor proteins. In 1975 the synthesis of methyltrienolone (MT) opened a new field in searching receptor proteins. This synthetic androgen discriminates between receptors and other proteins such as TeBG and albumin. The main purpose in this investigation was to obtain the electrophoretic patterns of human prostatic androgen-binding proteins and compare them with those of other tissues from male genital tract (e.g., testes and epididymis), using as a reference the already described pattern in blood serum. The experimentation was carried out with cytosol (105,000 g) and nuclear fractions from the homogenized tissue. Both fractions were incubated with the tritiated steroids and then treated with dextran-coated charcoal. Polyacrylamide gel electrophoresis (PAGE) was then performed at pH 8.3 with acrylamide (T) 7.7%. The prostatic cytosol incubated with 3H-dihydrotestosterone (3H-DHT) revealed radioactive areas with the following average electrophoretic mobilities relative to Bromophenol Blue (Rf): 0.195, 0.285, 0.815, 0.910. When cytosol was incubated with 3H-MT the pattern showed radioactive peaks with Rf 0.280, 0.570, and 0.969. The nuclear fraction bound 3H-DHT in 0.190, 0.455, 0.570, 0.660, and 1.055 and bound 3H-MT in Rf 1.01. We concluded from these results that the electrophoretic patterns in the prostate gland shared some radioactive areas resembling TeBG and albumin, although they present low binding capacity. The other peaks with different electrophoretic mobilities are in the process of further identification.

Seminal fluid androgen binding protein

The following study was undertaken to determine the presence of an androgen binding protein (ABP) in the ejaculate. Seminal fluid was obtained from ten fertile subjects. Sperm counts ranged from 20 x 106/cc to 80 x 106/cc. Each sample was preincubated with tritiated dihydrotestosterone (DHT) and examined by polyacrylamide gel electrophoresis (PAGE). Second, after preincubation of the samples with tritiated DHT, the samples were mixed with Concanavalin-A bound to sepharose-D (C-S) and the supernate separated and counted. Finally, saturation analysis of the samples using dextran-coated charcoal for separation and counted. Finally, saturation analysis of the samples using dextran-coated charcoal for separation was performed and Scatchard analysis was used to determine the concentration of ABP present. PAGE demonstrated ABP in seven of ten samples studied. The bound counts of DHT were removed by C-S. The concentrations of ABP ranged from 0.132 to 0.468 nanomoles ABP/dl semen. These data indicate there is an ABP in seminal fluid similar to that from the Sertoli cell.